Lifecore Biomedical Inc
NASDAQ:LFCR

Watchlist Manager
Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc
NASDAQ:LFCR
Watchlist
Price: 7.67 USD 0.92%
Market Cap: 282.5m USD
Have any thoughts about
Lifecore Biomedical Inc?
Write Note

Lifecore Biomedical Inc
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Lifecore Biomedical Inc
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Lifecore Biomedical Inc
NASDAQ:LFCR
Other Current Assets
$1.9m
CAGR 3-Years
-42%
CAGR 5-Years
-31%
CAGR 10-Years
-14%
Hershey Co
NYSE:HSY
Other Current Assets
$492.4m
CAGR 3-Years
35%
CAGR 5-Years
14%
CAGR 10-Years
6%
General Mills Inc
NYSE:GIS
Other Current Assets
$1.3B
CAGR 3-Years
-13%
CAGR 5-Years
26%
CAGR 10-Years
11%
Kellogg Co
NYSE:K
Other Current Assets
$368m
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
0%
Kraft Heinz Co
NASDAQ:KHC
Other Current Assets
$868m
CAGR 3-Years
-30%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Mondelez International Inc
NASDAQ:MDLZ
Other Current Assets
$2.7B
CAGR 3-Years
50%
CAGR 5-Years
18%
CAGR 10-Years
5%
No Stocks Found

Lifecore Biomedical Inc
Glance View

Market Cap
282.5m USD
Industry
Food Products

Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.

LFCR Intrinsic Value
10.95 USD
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Lifecore Biomedical Inc's Other Current Assets?
Other Current Assets
1.9m USD

Based on the financial report for Aug 25, 2024, Lifecore Biomedical Inc's Other Current Assets amounts to 1.9m USD.

What is Lifecore Biomedical Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
-14%

Over the last year, the Other Current Assets growth was -68%. The average annual Other Current Assets growth rates for Lifecore Biomedical Inc have been -42% over the past three years , -31% over the past five years , and -14% over the past ten years .

Back to Top